Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer

Tumori

Volumn 92, Issue 2, 2006, Pages 149-154

  Koç, Melike ^a   Ediger, Dane ^a   Budak, Ferah ^a   Karadaǧ, Mehmet ^a   Oral, Haluk Barbaros ^a   Uzaslan, Esra ^a   Ege, Ercüment ^a   Gözü, Ramazan Oktay ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

Bronchial lavage fluid; Lung cancer; Matrix metalloproteinase 9 (MMP 9); Serum

Indexed keywords

GELATINASE B; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; METASTASIS; SMOKING; STATISTICAL ANALYSIS; TRACHEOBRONCHIAL TOILET; BLOOD; BRONCHOSCOPY; COMPARATIVE STUDY; ENZYMOLOGY; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 33744727646     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160609200211     Document Type: Article

References (25)

1. Fidler J: Molecular biology of cancer: invasion and metastasis. In: Cancer: principles and practice of oncology, De Vita VT, Hellman S, Rosenberg SA (Eds), pp 135-137, Lippincott Williams & Wilkins, Philadelphia, 1997.
2. Desai SB, Libutti SK: Tumor angiogenesis and endothelial cell modulatory factors. J Immunother, 22: 186-211, 1999.
3. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol, 18: 1135-1149, 2000.
4. Kleiner DE, Stetler-Stevenson WG: Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol, 43 (Suppl): 42-51, 1999.
5. Shou Y, Hirano T, Gong Y, Kato Y, Yoshida K, Ohira T, Ikeda N, Konaka C, Ebihara Y, Zhao F, Kato H: Influence of angiogenetic factors and matrix metalloproteinases upon tumor progression in non-small-cell lung cancer. Br J Cancer, 85: 1706-1712, 2001.
6. Cox G, O'Byrne KJ: Matrix metalloproteinases and cancer. Anticancer Res, 21: 4207-4219, 2001.
7. Cox G, Jones JL, O'Byrne KJ: Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res, 6: 2349-2355, 2000.
8. Iizasa T, Fujisawa T, Suzuki M, Motohashi S, Yasufuku K, Yasukawa T, Baba M, Shiba M: Elevated levels of circulating plasma matrix metalloproteinase-9 in non-small-cell lung cancer. Clin Cancer Res, 5: 149-153, 1999.
9. Sienel W, Hellers J, Morresi-Hauf A, Lichtinghagen R, Mutschler W, Jochum M, Klein C, Passlick B, Pantel K: Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer. Int J Cancer, 103: 647-651, 2003.
10. Watanabe Y: TNM classification for lung cancer. Ann Thorac Cardiovasc Surg, 9: 343-350, 2003.
11. Mountain CF: The international system for staging lung cancer. Semin Surg Oncol, 18: 106-115, 2000.
12. Laack E, Kohler A, Kugler C, Dierlamm T, Knuffmann C, Vohwinkel G, Niestroy A, Dahlmann N, Peters A, Berger J, Fiedler W, Hossfeld DK: Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann Oncol, 13: 1550-1557, 2002.
13. Zucker S, Lysic RM, Zarrabi MH, Moll U: M(r) 92000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res, 53: 140-146, 1993.
14. Jumper C, Cobos E, Lox C: Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment. Respir Med, 98: 173-177, 2004.
15. Farias E, Ranuncolo S, Cresta C, Specterman S, Armanasco E, Varela M, Lastiri J, Pallotta MG, Bal de Kier Joffe E, Puricelli L: Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients. Int J Cancer, 89: 389-394, 2000.
16. Yang SF, Hsieh YS, Lin CL, Hsu NY, Chiou HL, Chou FP, Chu SC: Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients. Clin Chim Acta, 354: 91-99, 2005.
17. Bonomi P: Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol, 29: 78-86, 2002.
18. Ondo K, Sugio K, Yamazaki K, Yamaguchi M, Yano T, Yoshino I, Maehara Y: The significance of serum active matrix metalloproteinase-9 in patients with non-small cell lung cancer. Lung Cancer, 46: 205-213, 2004.
19. Ylisirnio S, Hoyhtya M, Turpeenniemi-Hujanen T: Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer - TIMP-1 as a prognostic marker. Anticancer Res, 20: 1311-1316, 2000.
20. O'Connor CM, FitzGerald MX: Matrix metalloproteinases and lung disease. Thorax, 49: 602-609, 1994.
21. Nakamura T, Ebiuhara I, Shimada N, Koide H: Effect of cigarette smoking on plasma metalloproteinase-9 concentration. Clin Chim Acta, 276: 173-177, 1998.
22. Ylisirnio S, Hoyhtya M, Makitaro R, Pakko P, Risteli J, Kinnula VL, Turpeenniemi-Hujanen T, Jukkola A: Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. Clin Cancer Res, 7: 1633-1637, 2001.
23. Tamura M, Oda M, Matsumoto I, Tsunezuka Y, Kawakami K, Ohta Y, Watanabe G: The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer. Ann Surg Oncol, 11: 928-933, 2004.
24. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N, Dano K: 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int J Cancer, 65: 57-62, 1996.
25. Hrabec E, Strek M, Nowak D, Greger J, Suwalski M, Hrabec Z: Activity of type IV collagenases (MMP-2 and MMP-9) in primer pulmonary carcinomas: a quantitative analysis. J Cancer Res Clin Oncol, 128: 197-204, 2002.